RecruitingNCT05750732

Weight Loss and CLOCK 3111T/C Polymorphism

Investigation of the Relationship Between Weight Loss Diet and Circadian Gene CLOCK 3111T/C Polymorphism


Sponsor

Hacettepe University

Enrollment

400 participants

Start Date

Feb 20, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

The goal of this observational study is to investigate the relationship of CLOCK 3111T/C (rs1801260) gene variant with nutritional habits, nutritional status, chronotype, sleep quality, some biochemical parameters in overweight or obese individuals and to observe its effect on weight loss diet intervention. The main questions it aims to answer are: * Is the frequency of carrying the CLOCK 3111T/C (rs1801260) gene risk allele different between individuals with normal body weight and those who are overweight or obese? * Do those with the CLOCK 3111T/C (rs1801260) risk allele have a higher frequency of evening chronotype and a shorter sleep duration? * Is the effect of CLOCK 3111T/C (rs1801260) gene alleles different on weight loss diet response in overweight or obese individuals? A questionnaire will be applied to the individuals in both groups (normal body weight and overweight/obese individuals) to evaluate their general characteristics, eating habits, adherence to Mediterranean diet, DASH and MIND. In addition, anthropometric measurements, 3-day food consumption record and 3-day physical activity record will be taken from individuals. CLOCK 3111T/C (rs1801260) gene variant analysis in whole blood, adiponectin and leptin hormones in serum samples will be studied. Participants those who are overweight/obese will be asked to follow a weight loss diet for 3 months. Researchers will compare participants with normal body weight and those who are overweight or obese to see if there is a difference between the frequency of carrying the CLOCK 3111T/C (rs1801260) gene risk allele.


Eligibility

Min Age: 20 YearsMax Age: 50 Years

Inclusion Criteria3

  • Be in the 20-50 age range
  • BMI in the range of 25-40 kg/m2 for the study group
  • BMI of 18.5-24.9 kg/m2 for the control group

Exclusion Criteria18

  • Those with type 1 diabetes
  • Those with Type 2 diabetes who take insulin therapy or use oral diabetes medication
  • Those who use drugs for weight loss
  • Those with unstable cardiovascular disease
  • Those with kidney or liver failure
  • Presence of diagnosed malabsorption (celiac disease, Crohn's, ulcerative colitis)
  • Those who have undergone bariatric surgery
  • Those who are pregnant or breastfeeding
  • Menopausal women
  • Those who use corticosteroids
  • Those with severe endocrine disorders (hypothyroidism, hyperthyroidism, hypopituitarism)
  • Those with psychiatric or neurological disease
  • Weight change of >5% in the last 6 months
  • Those with malignant tumors
  • Those with eating disorders
  • Shift workers
  • Relatives
  • People from different ethnic backgrounds

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALWeight loss diet

Participants in the study group will be given training on the weight loss diet, which is a routine part of their treatment.


Locations(1)

Hacettepe University

Ankara, Turkey (Türkiye)

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05750732


Related Trials